News and Press Releases

Syngene Collaborates with Johns Hopkins University to Advance Early-Stage Drug Discovery

India/UK/US, 11 February, 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug...

Category:
Posted: February 11, 2026

Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099

Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies

Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...

Category:
Posted: February 11, 2026

29 Everett Street, Holliston, MA 01746

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Global Headquarters 200 Technology Square Cambridge, MA 02139

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Financing led by Investissement Québec with continued support from long-standing investors Plans include the acceleration of clinical development of breakthrough GPCR targeting treatments for patients. 10 February 2026 -- Montreal,...

Category: Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

7171 Frederick Banting Montreal, QC H4S 1Z9 Canada

SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research

Automated workflow to be highlighted at SLAS 2026, 7-11 February, Boston Collaboration combines precision liquid handling technology with Transcreener ADP2 fluorescence polarization assay for screening of VPS4B ATPase inhibitors. 9...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 9, 2026

SPT Labtech Ltd. Melbourn Science Park Melbourn Hertfordshire SG8 6HB United Kingdom

ACG Packaging Materials Joins World Economic Forum’s Global Lighthouse Network as World’s First Pharmaceutical Packaging Company

ACG Packaging Materials today announced that its Shirwal facility has been named a global Lighthouse and welcomed into the World Economic Forum’s (WEF) Lighthouse Network (GLN). This marks ACG’s second...

Category:
Posted: February 5, 2026

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

ALTx Therapeutics launches into the Slingshot accelerator with £12.55 million of funding

Based on the pioneering work of British scientist Simon Boulton, ALTx leverages fundamental insights in cancer cell immortalisation to develop novel treatments for cancer Spinning out of The Francis Crick...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 5, 2026

Santec Announces the Opening of European Service Centre

4 February 2026 -- Komaki, Japan -- santec Holdings Corporation is pleased to announce the establishment of a new European service centre. The newly established subsidiary, Santec Europe Czech s.r.o....

Category: Drug Discovery, Other
Posted: February 4, 2026

5823, Ohkusa Nenjozaka, Komaki, Aichi, Japan 485-0802

Levicept Announces the Appointment of James Sandy as Chief Development Officer

Leadership Team Strengthened to Support Clinical Development of LEVI-04 for Osteoarthritis 4 February 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 4, 2026

Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia

Publication presents clinical findings highlighting evenamide’s glutamatergic modulation as a therapeutic strategy for patients with inadequate response or treatment-resistant schizophrenia (TRS) By targeting the hippocampus region of the brain, evenamide...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 3, 2026

via Antonio Meucci 3 20091 Bresso (Mi) Italy

Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation

ACES-EMB is the first randomized-controlled trial to compare dd-cfDNA surveillance to routine biopsy in organ transplantation, highlighting the benefits of Prospera in organ rejection 28 January 2026 -- Texas, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

13011 McCallen Pass Building A Suite 100 Austin, TX 78753

Johnson & Johnson receives CHMP positive opinion for AKEEGA (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with BRCA1/2 mutations

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen as a new standard...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

ALK receives positive CHMP opinion for EURneffy 1mg (nasal adrenaline spray) for emergency anaphylaxis treatment in children (≥15kg)

30 January 2026 -- Hørsholm – Denmark -- Today ALK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

Bøge Allé 6-8 DK-2970 Hørsholm Denmark

Samsung Bioepis Reaches Settlement Agreement for Eylea (Aflibercept) Biosimilar in Europe and the Rest of the World

30 January 2026 -- Incheon, Korea -- Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Regeneron and Bayer concerning the commercialization of SB15, a biosimilar to...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

76, Songdogyoyuk-ro, Yeonsu-gu, Incheon

Pharmapack announces expansion to Asia with new event in Singapore, set for November 2026

Paris, France – January 21st, 2026 – Pharmapack, the leading European platform for pharmaceutical packaging and drug delivery innovation, today announced the launch of Pharmapack Asia, coming to Singapore in...

Category:
Posted: January 30, 2026

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France